highly significantP < 0.001
baumannii , there was a highly significant increase in Trimethoprim-Sulfamethoxazole (87.1%) and Ciprofloxacin (94.0%) resistance in 2022 compared to the other two years ( P < 0.001).
baumannii , there was a highly significant increase in Trimethoprim-Sulfamethoxazole (87.1%) and Ciprofloxacin (94.0%) resistance in 2022 compared to the other two years ( P < 0.001).